3,4-Diaminopyridine for myasthenia gravis - Wikidata - wikimedia - TriplyDB

3,4-Diaminopyridine for myasthenia gravis

3,4-Diaminopyridine for myasthenia gravis

http://www.wikidata.org/entity/Q24203777

about

3,4-Diaminopyridine for myasthenia gravis

http://www.wikidata.org/entity/Q24203777

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

3,4-Diaminopyridine for myasthenia gravis

@ast

3,4-Diaminopyridine for myasthenia gravis

@en

3,4-Diaminopyridine for myasthenia gravis

@en-gb

3,4-Diaminopyridine for myasthenia gravis

@nl

type

label

3,4-Diaminopyridine for myasthenia gravis

@ast

3,4-Diaminopyridine for myasthenia gravis

@en

3,4-Diaminopyridine for myasthenia gravis

@en-gb

3,4-Diaminopyridine for myasthenia gravis

@nl

prefLabel

3,4-Diaminopyridine for myasthenia gravis

@ast

3,4-Diaminopyridine for myasthenia gravis

@en

3,4-Diaminopyridine for myasthenia gravis

@en-gb

3,4-Diaminopyridine for myasthenia gravis

@nl

P1433

Q24203777-A61B8356-8026-4E74-8C1F-09B0DD156067

P1476

Q24203777-11382086-0928-44AB-8440-32087181C197

P2093

Q24203777-041078A5-25E1-4B86-AED4-CEC136C1E30D

Q24203777-08E9BE96-F037-4E97-BDF8-91DC2B231AF8

Q24203777-22FD3AA1-322C-482A-BBB7-8B4B8858CA16

Q24203777-D1732CAF-9B3E-4266-915D-B3250CA52DDB

P2860

Q24203777-061DAF96-9C2C-46CC-87EF-8F87158A781C

Q24203777-1227FA1C-E399-4873-B248-4E6A03FC97F3

Q24203777-31A2CCF5-4A88-43AA-9761-B6AD882ACFB3

Q24203777-58E3EB7A-99F3-417E-8D35-DC37FFF3C326

Q24203777-5B2F4711-75EB-42FF-B71E-66C7BB890D90

Q24203777-5BAEA6F6-14A4-46D0-93BE-9DBB04BD3747

Q24203777-6DA41A5D-9A33-4B0B-8E70-A0462378B101

Q24203777-82F489C8-7F3A-465E-9819-9667001D270C

Q24203777-83AC25CA-C68E-49C1-92AC-91A2143DFBD7

Q24203777-871F7D74-7D7D-4841-A7C5-3C584AD7C8D1

P31

Q24203777-B82BC88E-6D0F-409C-A5E4-EDB2023DA1CE

P356

Q24203777-7830B9E0-5C63-4CA3-8FFC-F23C31D6AB9B

P577

Q24203777-03C3477F-745F-4C6F-8613-0ED249B8BDB6

P921

Q24203777-F59F1CA2-08B3-4154-9F0C-72EAC2AB27E9

P356

14651858.CD009675

P1433

Cochrane Database of Systematic Reviews

P1476

3,4-Diaminopyridine for myasthenia gravis

@en

P2093

Charlotte Vrinten

http://www.w3.org/2001/XMLSchema#string

Jan JGM Verschuuren

http://www.w3.org/2001/XMLSchema#string

Rob JPM Scholten

http://www.w3.org/2001/XMLSchema#string

Stephanie S. Weinreich

http://www.w3.org/2001/XMLSchema#string

P2860

Myasthenia gravis

Treatment for Lambert-Eaton myasthenic syndrome

Acetylcholinesterase inhibitor treatment for myasthenia gravis

Intravenous immunoglobulin for myasthenia gravis

Immunosuppressive agents for myasthenia gravis

Corticosteroids for myasthenia gravis

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

3,4-Diaminopyridine in the treatment of congenital (hereditary) myasthenia.

The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland.

Current therapy for Lambert-Eaton myasthenic syndrome: development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment.

P31

scholarly article

P356

10.1002/14651858.CD009675

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

myasthenia gravis